Purpose: To evaluate the efficacy of CXL in treating fungal keratitis as an adjuvant therapy.

Methods: Detailed clinical examination microbiological investigation was performed. Twenty fungal keratitis patients were recruited and randomized into two groups: group 1 (n= 11, standard antifungal), group 2 (n=9, corneal collagen crosslinking with standard antifungal). Corneal scraping and tear samples collected were subjected to real-time PCR targeting ITS, TLR analysis and cytokine analysis.

Results: The mean time for complete resolution of ulcer for group 2 was significantly shorter compared to group 1 and the final mean BCVA was better for group 2. Expression of IL-1β, IL-8, IFN-γ significantly decreased immediately post CXL in group 2 patients. Significant downregulation of TLR 6, TLR-3, TLR-4 was observed 3-days post CXL compared to group 1 patients.

Conclusion: Adjuvant effect of CXL was significant in treating fungal keratitis compared to standalone antifungal treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09273948.2020.1770296DOI Listing

Publication Analysis

Top Keywords

fungal keratitis
20
corneal collagen
8
collagen crosslinking
8
cxl treating
8
treating fungal
8
standard antifungal
8
compared group
8
post cxl
8
group
7
fungal
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!